Jubilant Pharmova Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is organising a Conference Call on October 22, 2021 after submission of the financial results for the quarter and half year ended September 30, 2021 to the Stock Exchanges. Details of the Conference Call are attached.

Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2021 ,inter alia, to consider and approve In terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, October 22, 2021, to inter-alia consider Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2021.

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Rajiv ShahDesignation :- Company Secretary and Compliance Officer

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

Pursuant to the provisions of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has issued duplicate share certificate to the member as per the attachment. This is for your information and record.

Jubilant Pharmova Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

This is further to our letter dated September 22, 2021. Pursuant to the provisions of Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following: 1. Details of the voting results in respect of the 43rd Annual General Meeting of the shareholders of the Company held on Wednesday, September 22, 2021 through Video Conferencing/ Other Audio Visual Means as Annexure 1. 2. Consolidated Scrutinizer''s Report pursuant to Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014 as Annexure 2. We request you to take the same on records.

Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from Friday, September 24, 2021 and the same shall remain closed till 48 hours after announcement of the financial results for the quarter ending September 30, 2021 to the Stock Exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. This is for your information and records.

Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be participating in Equirus Virtual Annual Conference, 2021 on September 27, 2021. We enclose details of the Investor/ Analyst for the same. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/ Company. We also enclose the presentation to be used during the Virtual Conference. This is for your information and record.